Treatment with dexamethasone, commonly used as ITP therapy restored the expression of miR-125a-5p in ITP CD4+ T cells, likely by suppressing MEG-3; it also promoted Treg differentiation. The gene discussed is CD4; the disease is autoimmune thrombocytopenic purpura.